Live feed
Filing
SC 13D
SC 13D0001437749-23-032344·INTEGRATED BIOPHARMA INC
Schedule 13D ownership disclosure
INTEGRATED BIOPHARMA INC
Security class unavailable
Event date: 2023-03-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,825,364
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-23-032344
- Form type
- SC 13D
- Filer
- INTEGRATED BIOPHARMA INC
- CIK
- CIK 1016504
- Filed
- Nov 16, 2023
- Reporting period
- Mar 20, 2023
- Description
- Schedule 13D beneficial ownership